Recombinant Human Galectin-2 (HEK-293-expressed) Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 9874-GA

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
9874-GA-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

HEK293

Accession #

P05162

Conjugate

Unconjugated

Applications

Bioactivity

View all Galectin-2 Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human Galectin-2 protein
Met1-Glu132

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Thr2

Predicted Molecular Mass

15 kDa

SDS-PAGE

12-15 kDa, reducing conditions

Activity

Measured by its ability to agglutinate human red blood cells. Hadari, Y.R. et al. (2000) J. Cell Sci. 113:2385.
The ED50 for this effect is 5-25 μg/mL.

Measured by the ability of the immobilized protein to enhance the adhesion of HUVEC human umbilical vein endothelial cells.
The ED50 for this effect is 1-6 μg/mL.

Scientific Data Images for Recombinant Human Galectin-2 (HEK-293-expressed) Protein, CF

Recombinant Human Galectin-2 (HEK-293-expressed) Protein Bioactivity

Recombinant Human Galectin-2 (HEK-293-expressed) Protein Bioactivity

Recombinant Human Galectin-2 (Catalog # 9874-GA) agglutinates human red blood cells. The ED50 for this effect is 5-25 μg/mL.
Recombinant Human Galectin-2 (HEK-293-expressed) Protein SDS-PAGE

Recombinant Human Galectin-2 (HEK-293-expressed) Protein SDS-PAGE

2 μg/lane of Recombinant Human Galectin‑2 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 12-15 kDa.

Formulation, Preparation and Storage

9874-GA
Formulation Lyophilized from a 0.2 μm filtered solution in HEPES, NaCl, TCEP, PEG and Trehalose.
Reconstitution
Reconstitute at 400 μg/mL in water.

Reconstitution Buffer Available:
Size / Price
Qty
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
  • 12 months from date of receipt, ≤ -20 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, ≤ -20 °C under sterile conditions after reconstitution.

Background: Galectin-2

Galectins constitute a large family of carbohydrate-binding proteins with specificity for N‑acetyl-lactosamine-containing glycoproteins. To date, 15 mammalian galectins, which share structural similarities in their carbohydrate-recognition domains (CRD), have been identified. Twelve galectin genes are found in humans, including two for galectin-9. The galectins have been classified into the prototype galectins (-1, -2, -5, -7, -10, -11, -13, -14, -15), which contain one CRD and exist either as a monomer or a noncovalent homodimer; the chimera galectin (galectin-3) containing one CRD linked to a nonlectin domain; and the tandem-repeat galectins (-4, -6, -8, -9, -12) consisting of two CRDs joined by a linker peptide. (1). Galectin-2 is an approximately 14-kDa homodimeric protein, and like other prototype galectins, consists of a single CRD (2-4). Human Galectin-2 shares 66% and 67% amino acid sequence identity with mouse and rat Galectin-2, respectively. Galectins lack a classical signal peptide and can be localized to the cytosolic compartments where they have intracellular functions. However, via one or more as yet unidentified non-classical secretory pathways, galectins can also be secreted to function extracellularly. Individual members of the galectin family have different tissue distribution profiles and exhibit subtle differences in their carbohydrate-binding specificities. Each family member may preferentially bind to a unique subset of cell-surface glycoproteins (5-7). Galectin-2 is expressed in hepatoma, stomach epithelial cells and in colorectal and neural tumors. The specific functions of Galectin-2 have not been reported but increased serum levels of Galectin-2 have been associated with metastatic cancer and this may also be involved in cancer cell adhesion to vascular endothelium (8).

References

  1. Cummings, R.D. and Liu, F. (2009) Essentials of Glycobiology. 2nd edition. Chapter 33.
  2. Hokama, A. et al. (2008) World J. Gastroenterol. 14:5133.
  3. Barondes, S.H. et al. (1994) Cell 76:597.
  4. Hirabayashi, J. and K. Kasai (1993) Glycobiology 3:297.
  5. Rabinovich, A. et al. (2002) Trends in Immunol. 23:313.
  6. Rabinovich, A. et al. (2002) J. Leukocyte Biology 71:741.
  7. Hughes, R.C. (2001) Biochimie 83:667.
  8. Barrow, H. et al. (2011) Clinical Cancer Research 22:7035.

Alternate Names

GAL2, Galectin2, LGALS2

Entrez Gene IDs

3957 (Human); 107753 (Mouse); 171134 (Rat)

Gene Symbol

LGALS2

UniProt

P05162

Additional Galectin-2 Products

Product Documents for Recombinant Human Galectin-2 (HEK-293-expressed) Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Galectin-2 (HEK-293-expressed) Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.